HealthEquity Inc. (NASDAQ:HQY) insider Stephen Neeleman sold 30,000 shares of HealthEquity stock in a transaction on Thursday, October 13th. The shares were sold at an average price of $36.19, for a total value of $1,085,700.00. Following the completion of the transaction, the insider now owns 30,000 shares in the company, valued at approximately $1,085,700. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Stephen Neeleman also recently made the following trade(s):

  • On Tuesday, September 13th, Stephen Neeleman sold 30,000 shares of HealthEquity stock. The shares were sold at an average price of $33.22, for a total value of $996,600.00.
  • On Tuesday, August 23rd, Stephen Neeleman sold 9,898 shares of HealthEquity stock. The shares were sold at an average price of $30.28, for a total value of $299,711.44.
  • On Thursday, August 18th, Stephen Neeleman sold 102 shares of HealthEquity stock. The shares were sold at an average price of $30.00, for a total value of $3,060.00.

Shares of HealthEquity Inc. (NASDAQ:HQY) opened at 36.40 on Wednesday. The stock’s 50 day moving average price is $35.86 and its 200-day moving average price is $29.73. The stock has a market capitalization of $2.13 billion, a price-to-earnings ratio of 93.33 and a beta of 1.62. HealthEquity Inc. has a 12 month low of $15.80 and a 12 month high of $38.80.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, September 6th. The company reported $0.16 EPS for the quarter, beating the Zacks’ consensus estimate of $0.13 by $0.03. HealthEquity had a net margin of 15.21% and a return on equity of 10.89%. The firm had revenue of $44.20 million for the quarter. During the same quarter last year, the firm posted $0.08 EPS. The business’s quarterly revenue was up 44.9% on a year-over-year basis. Equities analysts forecast that HealthEquity Inc. will post $0.51 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

Hedge funds have recently made changes to their positions in the stock. BlackRock Inc. boosted its stake in shares of HealthEquity by 56.5% in the second quarter. BlackRock Inc. now owns 3,594 shares of the company’s stock worth $109,000 after buying an additional 1,297 shares during the period. PineBridge Investments L.P. boosted its stake in shares of HealthEquity by 4.3% in the second quarter. PineBridge Investments L.P. now owns 4,482 shares of the company’s stock worth $137,000 after buying an additional 186 shares during the period. Teacher Retirement System of Texas boosted its stake in shares of HealthEquity by 43.9% in the second quarter. Teacher Retirement System of Texas now owns 6,061 shares of the company’s stock worth $184,000 after buying an additional 1,850 shares during the period. Denver Investment Advisors LLC acquired a new stake in shares of HealthEquity during the second quarter worth approximately $203,000. Finally, Mason Street Advisors LLC acquired a new stake in shares of HealthEquity during the second quarter worth approximately $210,000. Hedge funds and other institutional investors own 90.54% of the company’s stock.

HQY has been the topic of a number of research analyst reports. Raymond James Financial Inc. lifted their target price on HealthEquity from $32.00 to $40.00 and gave the company an “outperform” rating in a report on Monday, September 12th. Wells Fargo & Co. reiterated a “buy” rating on shares of HealthEquity in a report on Wednesday, June 22nd. Barrington Research lifted their target price on HealthEquity from $34.00 to $38.00 and gave the company an “outperform” rating in a report on Thursday, September 8th. Zacks Investment Research cut HealthEquity from a “buy” rating to a “hold” rating in a report on Friday, September 9th. Finally, Robert W. Baird raised their price objective on HealthEquity from $31.00 to $35.00 and gave the company a “neutral” rating in a research report on Wednesday, September 7th. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $36.00.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

5 Day Chart for NASDAQ:HQY

Receive News & Stock Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related stocks with our FREE daily email newsletter.